ACT Biotech Overview
ACT Biotech, in stealth mode, is a new company focused on developing and commercializing targeted oral cancer drugs. The company is a San Francisco-based ACT Biotech is a spinout of Bayer Healthcare.
Key People
No key people information added yet. Add key people information.
Funding
| Date | Type | Capital Amount | Post-Money Valuation | Investors |
|---|---|---|---|---|
| 05/09/2008 | Series A | 12M | Unknown |
Products
No product information added yet. Add product information.
Competitors
No competitors have been recorded yet. Add a competitor.
Related Companies
User Opinions
Bulls vs. Bears (0)
| Bullish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to succeed | ||||
| Bearish Opinions (0) | ||||
|---|---|---|---|---|
| Be the first to tell us why they are destined to stumble. | ||||
Discussions (0)
Start a New Discussion
Opinion Poll
View All Opinions »Web Metrics
View All Web Metrics »ACT Biotech on Twitter
Twitter Search »Discussions
View All Discussions »There are no discussions right now.
Recent Contributors
There are no recent contributors to this company.
Related Jobs
loading...
Jobs
by
SimplyHired

Profile
Opinions
